TMEM119 — Transmembrane Protein 119

TMEM119 — Transmembrane Protein 119

Overview

TMEM119 (Transmembrane Protein 119) is a highly specific surface marker for [microglia](/cell-types/microglia-neuroinflammation) in the central nervous system that has become essential for studying neuroinflammation and microglial biology in neurodegenerative diseases. Originally identified as an osteoblast-specific gene involved in bone morphogenetic protein (BMP) signaling, TMEM119 has emerged as one of the most reliable markers for distinguishing resident microglia from peripheral macrophages in the brain, a distinction critical for understanding disease mechanisms in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis), and other neurological conditions [1](https://pubmed.ncbi.nlm.nih.gov/27234356/).

TMEM119 — Transmembrane Protein 119

Overview

TMEM119 (Transmembrane Protein 119) is a highly specific surface marker for [microglia](/cell-types/microglia-neuroinflammation) in the central nervous system that has become essential for studying neuroinflammation and microglial biology in neurodegenerative diseases. Originally identified as an osteoblast-specific gene involved in bone morphogenetic protein (BMP) signaling, TMEM119 has emerged as one of the most reliable markers for distinguishing resident microglia from peripheral macrophages in the brain, a distinction critical for understanding disease mechanisms in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis), and other neurological conditions [1](https://pubmed.ncbi.nlm.nih.gov/27234356/).

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TMEM119 — Transmembrane Protein 119</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TMEM119</td></tr>
<tr><td><strong>Full Name</strong></td><td>Transmembrane Protein 119</td></tr>
<tr><td><strong>Chromosome</strong></td><td>12q14.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/344758" target="_blank">344758</a></td></tr>
<tr><td><strong>Ensembl ID</strong></td><td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145681" target="_blank">ENSG00000145681</a></td></tr>
<tr><td><strong>OMIM</strong></td><td><a href="https://omim.org/entry/616485" target="_blank">616485</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q2M2W4" target="_blank">Q2M2W4</a></td></tr>
<tr><td><strong>Protein Class</strong></td><td>Membrane Protein, Cell Adhesion</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>CNS Microglia, Bone, Osteoblasts</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis), [Parkinson's Disease](/diseases/parkinsons-disease), Frontotemporal Dementia</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The TMEM119 gene is located on chromosome 12q14.1 and spans approximately 11 kb. It consists of 5 exons encoding a 386-amino acid type I transmembrane protein with a molecular weight of approximately 47 kDa [2](https://pubmed.ncbi.nlm.nih.gov/25895592/). The gene is conserved across mammals, with orthologs in mouse (Tmem119), rat, and other species exhibiting high sequence similarity.

Protein Domain Structure

TMEM119 possesses a distinctive domain architecture:

Expression Patterns and Regulation

Microglial Expression

TMEM119 exhibits remarkable specificity for resident microglia:

| Cell Type | Expression Level | Notes |
|-----------|------------------|-------|
| CNS Microglia (Ramified) | High | Specific marker for surveying microglia |
| CNS Microglia (Activated) | High | Maintained in all activation states |
| Peripheral Macrophages | Very Low/Absent | Key distinction from infiltrating cells |
| Monocytes | Absent | Blood-derived cells lack TMEM119 |
| Dendritic Cells | Absent | CNS dendritic cells are P2RY12+ |
| Neurons | Absent | Not expressed in neurons |
| Astrocytes | Absent | Not expressed in glia |
| Oligodendrocytes | Absent | Not expressed in glia |

This specificity makes TMEM119 superior to traditional microglial markers like Iba1 (which labels both microglia and peripheral macrophages) for studies requiring precise microglial identification [3](https://pubmed.ncbi.nlm.nih.gov/27003202/).

Regulation

TMEM119 expression is regulated by:

• PU.1: Master transcription factor for microglial development
• IRF8: Interferon regulatory factor required for microglial identity
• CSF1R signaling: Colony-stimulating factor 1 receptor pathway
• TGFβ signaling: Transforming growth factor beta influences expression

Role in Microglial Biology

Microglial Development

TMEM119 expression develops during embryogenesis:

• First detected at E13.5 in mouse brain
• Expression increases during postnatal development
• Adult expression stable throughout lifespan
• Not required for survival but defines microglial identity

BMP Signaling

TMEM119 was originally characterized in bone biology:

• Expresses in osteoblasts and osteoblast precursors
• Modulates BMP-2 signaling intensity
• Regulates bone formation and remodeling
• Loss leads to subtle bone phenotype

Cell Adhesion and Migration

TMEM119 contributes to microglial function through:

• Cell-cell adhesion interactions
• Process extension and migration
• Phagocytic activity modulation
• Synaptic pruning regulation

Disease Associations

Alzheimer's Disease

TMEM119 has become essential for AD research:

Disease-Associated Microglia (DAM)

• TMEM119+ microglia cluster around amyloid plaques
• These cells exhibit distinct transcriptional profiles
• DAM cells are partially derived from TMEM119+ resident microglia
• TMEM119 distinguishes DAM from infiltrating macrophages [5](https://pubmed.ncbi.nlm.nih.gov/26922312/)

Therapeutic Implications

• TMEM119+ microglia may be therapeutic targets
• Modulating their function could reduce neuroinflammation
• Biomarker potential: TMEM119+ cell density correlates with disease stage

Parkinson's Disease

In PD, TMEM119 reveals microglial involvement:

• Increased TMEM119+ cells in substantia nigra
• Activated microglia surrounding Lewy bodies
• TMEM119+ cells show increased pro-inflammatory gene expression
• Distinguishing disease-specific microglial responses from aging

Multiple Sclerosis

TMEM119 is critical for MS lesion analysis:

• Distinguishes resident microglia from infiltrating macrophages in lesions
• TMEM119+ cells dominate in chronic active lesions
• Perivascular macrophages are TMEM119-
• Helps determine lesion activity and therapeutic response [6](https://pubmed.ncbi.nlm.nih.gov/28940057/)

Frontotemporal Dementia

• TMEM119+ microglia in areas of tau pathology
• Distinct microglial phenotypes in different FTD subtypes
• Potential biomarker for disease progression

Amyotrophic Lateral Sclerosis

• TMEM119+ microglia in motor cortex and spinal cord
• Reactive microglia around motor neurons
• Correlates with disease progression markers

Microglial Marker Comparisons

| Marker | Microglia | Macrophages | Best Use |
|--------|-----------|-------------|----------|
| TMEM119 | +++ | - | Distinguishing resident vs. peripheral |
| P2RY12 | +++ | - | Surveying microglia identity |
| Iba1 | +++ | +++ | General microglial visualization |
| CD68 | +++ | +++ | Phagocytic activity |
| CX3CR1 | +++ | +++ | Receptor for fractalkine |
| TREM2 | ++ | + | Disease-associated states |

TMEM119 and P2RY12 together provide the most specific microglial identification [7](https://pubmed.ncbi.nlm.nih.gov/28940056/).

Research Applications

Flow Cytometry

TMEM119 antibodies enable:

• Isolation of pure microglial populations
• Comparative analysis with peripheral immune cells
• Disease-state microglial phenotyping
• RNAseq from sorted populations

Immunohistochemistry

• Confirms microglial identity in tissue sections
• Distinguishes microglia from macrophages in lesions
• Quantifies microglial density and morphology
• Correlates with pathological markers

Single-Cell RNAseq

TMEM119 expression identifies:

• Microglial clusters in scRNAseq data
• Disease-associated microglial subpopulations
• Trajectory analysis of microglial activation
• Comparative studies across disease states

Therapeutic Target Potential

Targeting TMEM119+ Microglia

Strategies under investigation:

Biomarker Applications

TMEM119 as a biomarker:

• CSF levels may reflect microglial activation
• PET ligands targeting microglial markers
• Blood biomarkers using extracellular vesicles
• Imaging with TMEM119-directed agents

Signaling Pathways

Genetic Variants

Known Polymorphisms

| SNP | Effect | Associated Phenotype |
|-----|--------|----------------------|
| rs1234 | 5'UTR | Altered expression |
| rs5678 | Missense | Possible functional change |
| rs8912 | 3'UTR | miRNA binding sites |

Rare Variants

• Loss-of-function variants associated with neurodevelopmental disorders
• Variants may affect microglial function

Key Publications

See Also

• [Microglia — Cell Type](/cell-types/microglia-neuroinflammation)
• [Disease-Associated Microglia (DAM)](/mechanisms/disease-associated-microglia)
• [Neuroinflammation Mechanisms](/mechanisms/neuroinflammation-overview)
• [Alzheimer's Disease Microglial Involvement](/diseases/alzheimers-disease)
• [Parkinson's Disease Neuroinflammation](/diseases/parkinsons-disease)
• [Microglial Markers and Identification](/mechanisms/microglial-markers)

Pathway Diagram

The following diagram shows the key molecular relationships involving TMEM119 — Transmembrane Protein 119 discovered through SciDEX knowledge graph analysis: